Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Nuclear Medicine and Biology|December 18, 2021
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experienceJean-Pierre Pouget, Lore Santoro, Bérengère Piron, et al.Chemmedchem|June 3, 2015
MA-NOTMP: A Triazacyclononane Trimethylphosphinate Based Bifunctional Chelator for Gallium Radiolabelling of BiomoleculesSophie Poty, Pauline Désogère, Jakub Šimeček, et al.Nuclear Medicine and Biology|April 17, 2023
In vivo validation of <sup>68</sup>Ga-labeled AMD3100 conjugates for PET imaging of CXCR4Isaline Renard, Juozas Domarkas, Sophie Poty, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Leveraging Bioorthogonal Click Chemistry to Improve <sup>225</sup>Ac-Radioimmunotherapy of Pancreatic Ductal AdenocarcinomaSophie Poty, Lukas M Carter, Komal Mandleywala, et al.Dalton Transactions (Cambridge, England : 2003)|February 3, 2015
New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinitiesSophie Poty, Pauline Désogère, Christine Goze, et al.Molecular Pharmaceutics|October 13, 2025
Supramolecular Chemistry Enables Radiolabeling of Proteins under Mild ConditionsRomane Vizier, Milou Boswinkel, Mathieu Moreau, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using PretargetingSophie Poty, Laura Ordas, Yana Dekempeneer, et al.Nuclear Medicine and Biology|May 26, 2019
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticalsSai Kiran Sharma, Serge K Lyashchenko, Hijin A Park, et al.ACS Omega|August 29, 2019
Innovative Magnetic Nanoparticles for PET/MRI Bimodal ImagingGuillaume Thomas, Julien Boudon, Lionel Maurizi, et al.Pharmacology & Therapeutics|October 23, 2021
Therapeutic antibodies - natural and pathological barriers and strategies to overcome themYara Al Ojaimi, Timothée Blin, Juliette Lamamy, et al.Pageof 3